|
1
|
Flodrova D, Toporova L, Macejova D,
Lastovickova M, Brtko J and Bobalova J: A comparative study of
protein patterns of human estrogen receptor positive (MCF-7) and
negative (MDA-MB-231) breast cancer cell lines. Gen Physiol
Biophys. 35:387–392. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li T, Zhao J, Yang J, Ma X, Dai Q, Huang
H, Wang L and Liu P: A meta-analysis of the association between
ESR1 genetic variants and the risk of breast cancer. PLoS One.
11:e01533142016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tübel J, Kuntz L, Marthen C, Schmitt A,
Wiest I, Von Eisenhart-Rothe R, Jeschke U and Burgkart R:
Methylation of the ER-alpha promoter is influenced by its ligand
estrogen in osteosarcoma cells SAOS-2 in vitro. Anticancer Res.
36:3199–3204. 2016.PubMed/NCBI
|
|
4
|
Meng D, Li Z, Ma X, Fu L and Qin G:
MicroRNA-1280 modulates cell growth and invasion of thyroid
carcinoma through targeting estrogen receptor α. Cell Mol Biol
(Noisy-le-grand). 62:1–6. 2016.
|
|
5
|
Guo JJ, Yang DP, Tian X, Vemuri VK, Yin D,
Li C, Duclos RI Jr, Shen L, Ma X, Janero DR, et al: 17β-estradiol
(E2) in membranes: Orientation and dynamic properties. Biochim
Biophys Acta. 1858:344–353. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huan J, Wang L, Xing L, Qin X, Feng L, Pan
X and Zhu L: Insights into significant pathways and gene
interaction networks underlying breast cancer cell line MCF-7
treated with 17β-estradiol (E2). Gene. 533:346–355. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen KC, Lin CM, Huang CJ, Chen SK, Wu ST,
Chiang HS and Ku WC: Dual roles of 17-β estradiol in estrogen
receptor-dependent growth inhibition in renal cell carcinoma.
Cancer Genomics Proteomics. 13:219–230. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He X, Gao Z, Xu H, Zhang Z and Fu P: A
meta-analysis of randomized control trials of surgical methods with
osteosarcoma outcomes. J Orthop Surg. 12:52017. View Article : Google Scholar
|
|
9
|
Zhang W, Han S and Sun K: Combined
analysis of gene expression, miRNA expression and DNA methylation
profiles of osteosarcoma. Oncol Rep. 37:1175–1181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ren W and Gu G: Prognostic implications of
RB1 tumour suppressor gene alterations in the clinical outcome of
human osteosarcoma: A meta-analysis. Eur J Cancer Care (Engl).
27–October;2015.(Epub ahead of print). PubMed/NCBI
|
|
11
|
Wang Y, Guo W, Shen D, Tang X, Yang Y, Ji
T and Xu X: Surgical treatment of primary osteosarcoma of the
sacrum: A case series of 26 patients. Spine. Dec 16–2016.(Epub
ahead of print).
|
|
12
|
Zhang Z, Wang F, Li Q, Zhang H, Cui Y, Ma
C, Zhu J, Gu X and Sun Z: CD151 knockdown inhibits osteosarcoma
metastasis through the GSK-3β/β-catenin/MMP9 pathway. Oncol Rep.
35:1764–1770. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pu Y, Zhao F, Cai W, Meng X, Li Y and Cai
S: MiR-193a-3p and miR-193a-5p suppress the metastasis of human
osteosarcoma cells by down-regulating Rab27B and SRR, respectively.
Clin Exp Metastasis. 33:359–372. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yin Z, Ding H, He E, Chen J and Li M:
Up-regulation of microRNA-491-5p suppresses cell proliferation and
promotes apoptosis by targeting FOXP4 in human osteosarcoma. Cell
Prolif. Oct 5–2016.(Epub ahead of print).
|
|
15
|
Zhao H, Wu Y, Chen Y and Liu H: Clinical
significance of hypoxia-inducible factor 1 and VEGF-A in
osteosarcoma. Int J Clin Oncol. 20:1233–1243. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou G, Lu M, Chen J, Li C, Zhang J, Chen
J, Shi X and Wu S: Identification of miR-199a-5p in serum as
noninvasive biomarkers for detecting and monitoring osteosarcoma.
Tumour Biol. 36:8845–8852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mochizuki S, Yoshida S, Yamanaka Y, Matsuo
H and Maruo T: Effects of estriol on proliferative activity and
expression of insulin-like growth factor-I (IGF-I) and IGF-I
receptor mRNA in cultured human osteoblast-like osteosarcoma cells.
Gynecol Endocrinol. 20:6–12. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Muir M, Romalo G, Wolf L, Elger W and
Schweikert HU: Estrone sulfate is a major source of local estrogen
formation in human bone. J Clin Endocrinol Metab. 89:4685–4692.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gilligan LC, Gondal A, Tang V, Hussain MT,
Arvaniti A, Hewitt AM and Foster PA: Estrone sulfate transport and
steroid sulfatase activity in colorectal cancer: Implications for
hormone replacement therapy. Front Pharmacol. 8:1032017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Robarge JD, Desta Z, Nguyen AT, Li L,
Hertz D, Rae JM, Hayes DF, Storniolo AM, Stearns V, Flockhart DA,
et al: Effects of exemestane and letrozole therapy on plasma
concentrations of estrogens in a randomized trial of postmenopausal
women with breast cancer. Breast Cancer Res Treat. 71:453–461.
2017. View Article : Google Scholar
|
|
21
|
Fang D, Yang H, Lin J, Teng Y, Jiang Y,
Chen J and Li Y: 17β-estradiol regulates cell proliferation, colony
formation, migration, invasion and promotes apoptosis by
upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell
MG-63 in an estrogen receptor-independent manner. Biochem Biophys
Res Commun. 457:500–506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stossi F, Barnett DH, Frasor J, Komm B,
Lyttle CR and Katzenellenbogen BS: Transcriptional profiling of
estrogen-regulated gene expression via estrogen receptor (ER) alpha
or ERbeta in human osteosarcoma cells: Distinct and common target
genes for these receptors. Endocrinology. 145:3473–3486. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Langmead B and Salzberg SL: Fast
gapped-read alignment with Bowtie 2. Nat Methods. 9:357–359. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Feng J, Liu T, Qin B, Zhang Y and Liu XS:
Identifying ChIP-seq enrichment using MACS. Nat Protoc.
7:1728–1740. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu G, Wang LG and He QY: ChIPseeker: An
R/Bioconductor package for ChIP peak annotation, comparison and
visualization. Bioinformatics. 31:2382–2383. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ramírez F, Dündar F, Diehl S, Grüning BA
and Manke T: deepTools: A flexible platform for exploring
deep-sequencing data. Nucleic Acids Res. 42W1:W187–W191. 2014.
View Article : Google Scholar
|
|
27
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy - analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Diboun I, Wernisch L, Orengo CA and
Koltzenburg M: Microarray analysis after RNA amplification can
detect pronounced differences in gene expression using limma. BMC
Genomics. 7:2522006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for Annotation,
Visualization, and Integrated Discovery. Genome Biol. 4:32003.
View Article : Google Scholar
|
|
30
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk - Database: Prediction of possible miRNA binding sites by
‘walking’ the genes of three genomes. J Biomed Inform. 44:839–847.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu Q, Li S, Chen C, Zhu M, Chen Y and Zhao
Z: 17β-Estradiol treatment drives Sp1 to upregulate MALAT-1
expression and epigenetically affects physiological processes in
U2OS cells. Mol Med Rep. 15:1335–1342. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
You G, Feng L, Yan W, Zhang W, Wang YZ, Li
SW, Li SW, Li GL, Song YJ, Kang CS, et al: BCL2A1 is a potential
biomarker for postoperative seizure control in patients with
low-grade gliomas. CNS Neurosci Ther. 19:882–888. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hind CK, Carter MJ, Harris CL, Chan HT,
James S and Cragg MS: Role of the pro-survival molecule Bfl-1 in
melanoma. Int J Biochem Cell Biol. 59:94–102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiao P, Chen Y, Jiang H, Liu YZ, Pan F,
Yang TL, Tang ZH, Larsen JA, Lappe JM, Recker RR, et al: In vivo
genome-wide expression study on human circulating B cells suggests
a novel ESR1 and MAPK3 network for postmenopausal osteoporosis. J
Bone Miner Res. 23:644–654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lin J and Lei Z: Chromatin
immunoprecipitation with estrogen receptor 1 and the promoter of
Greb1 in TM4 sertoli cells. Methods Mol Biol. 1366:67–77. 2016.
View Article : Google Scholar : PubMed/NCBI
|
